Australia markets close in 4 hours 22 minutes

Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
12.700.00 (0.00%)
At close: 11:37AM EST

Fisher & Paykel Healthcare Corporation Limited

15 Maurice Paykel Place
East Tamaki
Auckland 2013
New Zealand
64 9 574 0100
https://www.fphcare.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees6,769

Key executives

NameTitlePayExercisedYear born
Mr. Lewis G. GradonMD, CEO & Exec. Director1.83MN/A1961
Ms. Lyndal YorkChief Financial OfficerN/AN/AN/A
Dr. Andrew SomervellVP of Products & TechnologyN/AN/AN/A
Hayden BrownInvestor Relations Mang.N/AN/AN/A
Karen KnottGen. Mang. of Corp. CommunicationsN/AN/AN/A
Mr. Paul N. Shearer B.Com.Sr. VP of Sales & MarketingN/AN/AN/A
Ms. Nicola TalbotVP of HRN/AN/AN/A
Mr. Jonathan RhodesVP of Supply Chain, Facilities & SustainabilityN/AN/AN/A
Mr. Marcus DrillerVP of Corp. & Company Sec.N/AN/AN/A
Chris CroneGen. Mang. of Airvo OptiflowN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Corporate governance

Fisher & Paykel Healthcare Corporation Limited’s ISS governance QualityScore as of 28 November 2022 is 8. The pillar scores are Audit: 10; Board: 5; Shareholder rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.